Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOBI for Early P. aeruginosa in CF Children
NCT01082367Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tobramycin in Pseudomonas aeruginosa infection, sponsored by Novartis. Started Apr 2010; status: completed.
02
Drugs
tobramycin
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01082367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082367.